|
containing
the following information:
|
(A) the name and purpose of the medication or |
epinephrine auto-injector ;
|
(B) the prescribed dosage; and
|
(C) the time or times at which or the special |
circumstances
under which the medication or |
epinephrine auto-injector is to be administered.
|
The information provided shall be kept on file in the office of |
the school
nurse or,
in the absence of a school nurse, the |
school's administrator.
|
(c) The school district or nonpublic school must inform the |
parents or
guardians of the
pupil, in writing, that the school |
district or nonpublic school and its
employees and
agents
are |
to incur no liability, except for willful and wanton conduct, |
as a result
of any injury arising from the
self-administration |
of medication or use of an epinephrine auto-injector by the |
pupil. The parents or guardians
of the pupil must sign a |
statement acknowledging that the school district
or nonpublic |
school is to incur no liability, except for willful and wanton
|
conduct, as a result of any injury arising
from the
|
self-administration of medication or use of an epinephrine |
auto-injector by the pupil and that the parents or
guardians |
must indemnify and hold harmless the school district or |
nonpublic
school and
its
employees and agents against any |
claims, except a claim based on willful and
wanton conduct, |
arising out of the
self-administration of medication or use of |
an epinephrine auto-injector by the pupil.
|
(d) The permission for self-administration of medication |
or use of an epinephrine auto-injector is effective
for the |
school year for which it is granted and shall be renewed each
|
subsequent school year upon fulfillment of the requirements of |
this
Section.
|
(e) Provided that the requirements of this Section are |
fulfilled, a
pupil with asthma may possess and use his or her |
medication or a pupil may possess and use an epinephrine |
auto-injector (i) while in
school, (ii) while at a |